bupropion sustained-release / Generic mfg.  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bupropion sustained-release / Generic mfg.
ChiCTR2300072489: A Single-Center, Open, Fixed-Sequence Phase I Clinical Study to Evaluate the Pharmacokinetic Effects of Multiple Doses of Desidustat Tablets on Single Dose of Bupropion Hydrochloride Sustained-Release Tablets in Healthy Subjects

Not yet recruiting
1
16
 
Desidustat tablets 150 mg, D4, D6, D8, D10, administered 4 times, Bupropion hydrochloride sustained-release tablets 150 mg, D1, D10, administered twice
Henan Privince Hospital of Traditional Chinese Medicine; Kangzhe (Hunan) Pharmaceutical Co., Ltd., Sponsor
Renal anemia
 
 
ChiCTR2300072490: A single-center, open, fixed-sequence phase I clinical study to evaluate the pharmacokinetics of multiple doses of Desidustat Tablets on a single dose of rosuvastatin calcium tablets in healthy subjects

Not yet recruiting
1
24
 
Desidustat tablets 150 mg, D4, D6, D8, D10, administered 4 times, Bupropion hydrochloride sustained-release tablets 150 mg, D1, D10, administered twice
Henan Privince Hospital of Traditional Chinese Medicine; Kangzhe (Hunan) Pharmaceutical Co., Ltd., Sponsor
Renal anemia
 
 

Download Options